-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster II

Symposia: Disorders of Platelet Number or Function: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Bleeding and Clotting, Autoimmune disorders, Fundamental Science, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Drug development, Translational Research, Epidemiology, Autoimmune hemolytic anemia, Elderly, Genomics, Platelet disorders, Clinical Research, Health outcomes research, Pediatric, Diseases, Immune Disorders, Immune mechanism, Thrombocytopenias, Therapy sequence, Patient-reported outcomes, Treatment Considerations, Biological therapies, Immunology, Real-world evidence, Pregnant, Adverse Events, Registries, Young adult , Biological Processes, Microbiome, Technology and Procedures, Study Population, Human, Maternal Health, Omics technologies
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Shelly Saini, MD1, Andrew Y. Koh, MD2* and Ayesha Zia, MD, MSc2

1Dept. of Pediatrics, UT Southwestern Medical Center, Dallas, TX
2Dept. of Pediatrics; Division of Hematology-Oncology, UT Southwestern Medical Center, Dallas, TX

Waleed Ghanima, MD, PhD1, Howard A. Liebman, MD, MA2, Yu Hu3*, Yoshitaka Miyakawa, MD4*, Nichola Cooper, MD5*, Güray Saydam, MD6*, Marie Luise Hütter-Krönke, MD7*, Sylvain Audia8*, Mengjie Yao9*, Ahmed Daak, MD, PhD, MSc, DPM/MFPM10, Imene Gouia, PharmD, MSc Health Economics11*, Matias Cordoba, MD12* and David J Kuter, MD, DPhil13

1Østfold Hospital Trust, Grålum, Norway and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
2University of Southern California, Los Angeles, CA
3Wuhan Xie'he Hospital, Wuhan, China
4Department of Hematology, Saitama Medical University, Saitama, Japan
5Hammersmith Hospital, London, United Kingdom
6Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Ege University, Izmir, Turkey
7Department of Hematology, Oncology and Tumorimmunology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany
8CHU Dijon Bourgogne - Hopital Francois Mitterrand, Dijon, France
9Sanofi, Bridgewater, NJ
10Sanofi, Cambridge, MA
11HEVA, Sanofi, Chilly-Mazarin, France
12Global Medical, Sanofi, Cambridge, MA
13Hematology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Yu Yang, MD1,2,3*, Huiyuan Li1,2,4*, Xiaofan Liu, MD1,3,5*, Hong Wang, MD3*, Lei Zhang1,4,5 and Renchi Yang, MD1,2,3

1School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
2Tianjin Institutes of Health Science, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
5Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Vivianne S. Nelson1,2,3*, Sufia N. Amini, MD, PhD3*, Tanja Netelenbos, MD, PhD3, Marina Kartachova, MD, PhD4*, Roger EG Schutgens, MD, PhD, MSc5*, Otto Visser, MD PhD6*, Peter E. Westerweel7, Jaap Jan Zwaginga, MD, PhD2, Suzanne Hofstede-Van Egmond8*, Rick Kapur, MD, PhD1, Masja De Haas2,9*, Leendert Porcelijn, MD8* and Martin R. Schipperus, MD, PhD10*

1Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands
2Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
3Department of Hematology, HagaZiekenhuis, Den Haag, Netherlands
4Department of Nuclear Medicine, HagaZiekenhuis, The Hague, Netherlands
5Center for Benign Hematology, Thrombosis and Hemostasis - Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
6Department of Hematology, Isala Hospital, Zwolle, Netherlands
7Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
8Department of Immunohematology Diagnostics, Sanquin Diagnostic Services, Amsterdam, Netherlands
9Department of Immunohematology Diagnostics, Sanquin Research Institute, Amsterdam, the Netherlands, Amsterdam, Netherlands
10Department of Clinical Affairs, Sanquin Blood Bank, Amsterdam, Netherlands

Tomas Jose Gonzalez-Lopez, MD1, Nuria Bermejo-Vega2*, Rocío Cardesa-Cabrera3*, Natalia Acedo Dominguez4*, Josefa Luis-Navarro5*, Sunil Lakhwani6*, Silvia Bernat7*, Guillermo Enrique Haces-Tirado8*, Pilar Galán9*, Maria Luisa Lozano10*, Daniel Martinez Carballeira11*, Roberto Hernandez12*, Reyes Jimenez Barcenas13*, Begoña Navas-Elorza14*, Shally Marcellini15*, Ana Torres-Tienza16*, Alvaro Perona Blazquez17*, Carmen Benet18*, Dolores Fernandez-Jimenez19*, Carolina López-Santamaría Castro20*, Isidro Jarque21*, Violeta Martínez Robles22*, Isabel González-Gascón-y-Marín23* and Gloria García-Donas Gabaldón24*

1Department of Hematology, Hospital Universitario de Burgos, Burgos, Spain
2Department of Hematology, Complejo Hospitalario Universitario de Cáceres, Caceres, ESP
3Hospital Público Comarcal de La Merced, Osuna, Seville, ESP
4Hospital Universitario de La Princesa, Madrid, ESP
5Hospital General de Riotinto, Minas de Riotinto, Huelva, Spain
6Hospital Universitario de Canarias, La Laguna, Spain
7Hospital Universitario de La Plana, Villareal, Castellón, Spain, Villareal, Spain
8Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
9Complejo Asistencial de Segovia, Segovia, ESP
10Hospital Morales Meseguer, Murcia, ESP
11Hospital Universitario Central de Asturias, Oviedo (Asturias), Spain
12Complejo Asistencial de Zamora, Zamora, Spain
13Hospital de la Serranía de Ronda, Ronda, Málaga., Ronda (Málaga), Spain
14Hospital Clínico San Carlos, Madrid, ESP
15Complejo Asistencial de Segovia, Segovia, Spain
16Hospital General de Segovia, Segovia, Spain, Segovia, Spain
17Complejo Hospitalario Universitario de Albacete, Albacete, Spain
18Hospital Arnau de Vilanova, Valencia, Spain
19Hospital Universitario San Cecilio, Granada, Spain, Granada, Spain
20Hospital Universitario de Badajoz, Badajoz, Spain
21Hematology Department, Hospital Universitari i Politècnic La Fe, Centro de Investigación Biomédica en Red de Cáncer – CIBERONC, Valencia, Spain
22Complejo Asistencial Universitario de León, León, Spain
23Hospital Universitario Infanta Leonor, Madrid, Spain
24Hospital Universitario Virgen Macarena, Sevilla, Spain

Lamya Garabet, MD, PhD1,2*, Waleed Ghanima, MD, PhD1, Åse-Berit Mathisen1*, Stine Jeanette Lae1*, Marie Skogstad Le3*, James B. Bussel, MD4, Andreas Hillarp, MD, PhD3* and Carola Henriksson, MD, PhD3*

1Ostfold Hospital Trust, Grålum, Norway
2Akershus University Hospital, Lørenskog, Norway
3Oslo University Hospital, Oslo, Norway
4Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY

Shaan D. Shah1*, Dinesh A. Rathod, MD2,3*, Nita D. Rathod, MD4*, Gaurang B. Modi, MD, DM5* and Aarti H. Vibhakar, MD3,6*

1B.J. Medical College, Ahmedabad, India
2Green Cross Genetics Lab Pvt. Ltd., Gandhinagar, India
3Hematology Clinic, 402, Narayan Complex, Ahmedabad, India
4Department of Physiology, Narendra Modi Medical College, Ahmedabad, India
5Oncowin Cancer Center, Ahmedabad, India
6Purelab, Al Qassimi Hospital, Sharjah, United Arab Emirates

Yu Hu1*, Renchi Yang, MD2, Xiaofan Liu, MD2*, Heng Mei, md, phd3*, Hu Zhou4, Shujie Wang5*, Ruibin Huang, MD6*, Yi Wang7*, Xin Du8*, Jing Sun9*, Zeping Zhou10*, Zhenyu Yan11*, Wenming Chen12*, Wei Wang13*, Qingchi Liu14*, Qingshu Zeng15*, Yuping Gong16*, Jie Yin17*, Xuliang Shen18*, Baodong Ye19*, Yun Chen20*, Yajing Xu, MD21*, Huiping Sun22*, Yunfeng Cheng23, Zhuogang Liu24*, Chunling Wang, PhD25*, Guolin Yuan26*, Xiaohui Zhang27, Xin Li28*, Peng Cheng29*, Xinhong Guo30*, Zhongxing Jiang31*, Feng'e Yang32*, Linhua Yang33*, Chengwei Luo Luo, M.D.34*, Taiwu Xiao35*, Hongyan Yin36*, Xiaojun Guo36*, Xian Luo36*, Songhua Fan36*, Michael M. Shi36* and Weiguo Su36*

1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
3Union Hospital, Tongji Medical College, HUST, Wuhan, China
4Department of Hematology, Henan Provincial Cancer Hospital, Zhengzhou, China
5Peking Union Medical College Hospital, Beijing, China
6The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
7Shaanxi Provincial People's Hospital, Xi'an, China
8Department of Hematology and Shenzhen Bone Marrow Transplantation Public Service Platform, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
9Nanfang Hospital Southern Medical University, Guangzhou, China
10Second Affiliated Hospital of Kunming Medical University, Kunming, China
11North China University of Science and Technology Affiliated Hospital, Tangshan, China
12Beijing Chaoyang Hospital Affiliated to Capital Medical University, Beijing, China
13The Affiliated Hospital of Qingdao University, Qingdao, China
14The First Hospital of Hebei Medical University, Shijiazhuang, China
15Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
16West China Hospital of Sichuan University, Chengdu, China
17First Affiliated Hospital of Soochow University, Suzhou, China
18Heping Hospital Affiliated To Changzhi Medical College, Changzhi, China
19The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China
20Central Hospital Affiliated to Shandong First Medical University, Jinan, China
21Xiangya Hospital, Central South University, Changsha, Hunan, China
22Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
23Jinshan Hospital of Fudan University, Shanghai, China
24Shengjing Hospital of China Medical University, Shenyang, China
25Department of Hematology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai'an, China
26Xiangyang Central Hospital, Xiangyang, China
27Peking University People's Hospital, Beijing, China
28Department of Hematology, Third Xiangya Hospital of Central South University, Changsha, China
29The First Affiliated Hospital of Guangxi Medical University, Nanning, China
30The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
31The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
32Fujian Medical University Union Hospital, Fuzhou, China
33The Second Hospital of Shanxi Medical University, Taiyuan, China
34Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
35Liaocheng People's hospital, Liaocheng, CHN
36HUTCHMED Limited, Shanghai, China

Michael D Tarantino, MD1, Scott Kolodny, MD2*, Michael Marrone, PhD2*, Brian Jamieson2 and Michael Vredenburg, PhD2*

1Bleeding and Clotting Disorders Institute, Peoria, IL
2Sobi Inc., Waltham, MA

Michael D Tarantino, MD1, Scott Kolodny, MD2*, Jessica Zhang, MS2*, Brian Jamieson2 and Michael Vredenburg, PhD2*

1Bleeding and Clotting Disorders Institute, Peoria, IL
2Sobi Inc., Waltham, MA

Jun Li1*, Xiaoli Li2* and Xiaofan Zhu, MD3

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
2Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, tianjin, China
3Tianjin Institutes of Health Science, Tianjin, China

Julia Manasson, MD*, Liliana Sanmarco, PhD*, Alex Pellerin, PhD*, Jordan Anderson, PhD*, Nathan Rollins, PhD*, Tobias Green, BS*, Agustin Plasencia, BS*, Andita Newton, MS*, Ryan Peckner, PhD*, Yi Xing, PhD*, Heather Vital, MBA*, Nathan Higginson-Scott, PhD*, John S Sundy, MD, PhD*, Kevin L Otipoby, PhD* and Ivan Mascanfroni, PhD*

Seismic Therapeutic, Watertown, MA

Kannan Meganathan, PhD1*, Samarjit Maharana, PhD1*, Chitrali Laha Roy, M.Sc1*, Fakiha Siddiqui, BDS2*, Ravi Ranjan, PhD3*, Jawed Fareed, PhD4, Manoranjan Mahapatra, MD3* and Renu Saxena, MD3*

1Department of Biotechnology (Formerly known as Department of Life Sciences), Central University of Tamil Nadu, Thiruvarur, Tamilnadu, India
2Department of Molecular Pharmacology and Neuroscience, Loyola University Medical Center, Maywood, IL
3Department of Hematology, All India Institute of Medical Sciences, New Delhi, India
4Department of Molecular Pharmacology and Neuroscience, Department of Pathology and Laboratory Medicine, Cardiovascular Research Institute, Health Science Division, Loyola University Chicago, Maywood, IL

Dawid Mehlich, MD, PhD1*, Ayobami Olafimihan, MBBS1, Alejandro Vallejo, DO1* and Shelby D. Rifkin, MD2

1Medicine, John H. Stroger Jr. Hospital of Cook County, Chicago, IL
2Hematology & Oncology, John H. Stroger Jr. Hospital of Cook County, Chicago

Donald Arnold, MD1, Yang Liu, MMath1*, Na Li, PhD2*, Madison Cranstone1*, Syed Mahamad, MSc1* and Ishac Nazy, PhD3

1Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, ON, Canada
2Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
3Michael G. DeGroote School of Medicine, Department of Medicine, McMaster University, Hamilton, ON, Canada

Kexin Shen*, Chen Zhao*, Lulu Wang*, Mengtong Zang*, Peng Zhao*, Zhuo-Yu An*, Xiaolu Zhu*, Qiusha Huang, MD*, HaiXia Fu, MD*, Xiaojun Huang and Xiaohui Zhang, MD

Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

Candelaria O'Farrell, MD1, Taylor M. Luckie, MD1, Susan E. Kirk, PA-C2*, Jennifer Geris3*, Michael E. Scheurer, PhD4 and Amanda B. Grimes, MD5,6

1Texas Children's Hospital / Baylor College of Medicine, Houston, TX
2Cancer and Hematology Center, Texas Children's Hospital, Houston, TX
3University of Minnesota, Minneapolis, MN
4Department of Pediatrics, Baylor College of Medicine, Houston, TX
5Texas Children’s Cancer and Hematology Center, Houston, TX
6Baylor College of Medicine, Houston, TX

Karan Srisurapanont, MD1*, Ekdanai Uawithya, MD2*, Pojsakorn Danpanichkul, MD3*, Rinrada Worapongpaiboon, MD4* and Chatree Chai-Adisaksopha, M.D., Ph.D.1,5*

1Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
2Division of Neurology, Department of Internal Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
3Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX
4Department of Medicine, Ratchaburi Hospital, Bangkok, Thailand
5Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand

Elena Monzón Manzano, PhD1*, María Teresa Alvarez-Román, PhD, MD1,2*, Lucía del Pino, PhD3*, Paula Acuña1*, Rick Kapur, MD, PhD4, Leendert Porcelijn, MD5*, Monica Martin Salces, PhD, MD1*, Elena G Arias-Salgado, PhD1*, Maria Isabel Rivas Pollmar, PhD, MD1*, Ana Mendoza1*, Eduardo López Granados3*, Victor Jimenez Yuste, MD, PhD1,2* and Nora Butta, PhD1*

1Hospital Universitario La Paz-IdiPAZ, Madrid, Spain
2Faculty of Medicine, Universidad Autonoma de Madrid, Madrid, Spain
3Servicio de Inmunología Clínica, Hospital Universitario La Paz- Grupo de Fisiopatología Linfocitaria en Inmunodeficiencias IdiPAZ y Centro de Investigación Biomédica en Red de Enfermedades Raras(CIBERER U767), Madrid, Spain
4Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands
5Department of Immunohematology Diagnostics, Sanquin Diagnostic Services, Amsterdam, Netherlands

Jing Zhang1*, Jia Chen, MD1*, Renchi Yang, MD2* and Lei Zhang3

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, C, TIianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Hanny Al-Samkari, MD1, Vickie McDonald, MD, PhD, FRPATH, MRCP2*, Monica Carpenedo, MD3*, Francesco Zaja, MD4*, Nichola Cooper, MD5*, Spero Cataland, MD6, Michael W Drazer, MD, PhD7, Yoshitaka Miyakawa, MD8*, Marc Michel, MD9*, Jaume Ayguasanosa, MD10*, Janki Brahmbhatt, MD10*, Lan Lan, PhD10*, Filip Matthijssens, PhD10*, Catherine M. Broome, MD11 and Waleed Ghanima, MD12*

1Division of Hematology Oncology, Massachusetts General Hospital, Boston, MA
2Barts Health NHS Trust, The Royal London Hospital, London, United Kingdom
3Ospedale L. Sacco, ASST Fatebenefratelli-Sacco, Milan, Italy
4DSM, University of Trieste and Department of Hematology, Azienda Sanitaria Universitaria Giuliano-Isontina, Trieste, Italy
5Imperial College Healthcare NHS Trust, London, United Kingdom
6Division of Hematology, The Ohio State University, Columbus, OH
7Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL
8Department of Hematology, Saitama Medical University Hospital, Saitama, Japan
9Department of Internal Medicine, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Paris-Est Créteil University, Créteil, France
10argenx, Ghent, Belgium
11Division of Hematology, MedStar Georgetown University Hospital, Washington, DC, USA, Washington
12Østfold Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway

*signifies non-member of ASH